Global Blood Therapeutics Inc
Change company Symbol lookup
Select an option...
GBT Global Blood Therapeutics Inc
MTLS Materialise NV
AFYA Afya Ltd
CSTR CapStar Financial Holdings Inc
ES Eversource Energy
AMKR Amkor Technology Inc
CMSC CMS Energy Corp
INTA Intapp Inc
OMCL Omnicell Inc
MPACU Model Performance Acquisition Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD). The Company is evaluating GBT440 in SCD in a Phase III clinical trial of GBT440 in adult and adolescent patients with SCD. GBT440 inhibits abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. The Company is also engaged in other research and development activities targeted towards hereditary angioedema (HAE). The Company's GBT440 is an investigational drug that increases hemoglobin's affinity for oxygen by binding to the alpha-chain of hemoglobin. GBT440 has been observed to keep a proportion of sickle hemoglobin (HbS), in its oxygenated state, where it cannot participate in polymerization.

Postmarket

Last Trade
Delayed
$29.15
0.94 (3.33%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$28.21
Day's Change
-0.48 (-1.67%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
29.16
Day's Low
28.08
Volume
(Light)
Volume:
744,375

10-day average volume:
1,210,398
744,375
  • Prev Close
    28.69
  • Today's Open
    28.57
  • Day's Range
    28.08-29.16
  • Avg Vol (10-day)
    1.2M
  • Last (time)
    4:00p ET 07/26/21
  • Last (size)
    242
  • 52-Wk Range
    28.08 - 72.79
    LowHigh
  • (07/29/20 - 07/26/21)
    0.46%
  • 67.7%
  • Market Cap
    1.8B
  • Shares Outstanding
    62.3M
  • -4.04
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 104.36
  • (% of float 06/30/21)
    22.47

Latest News

July 22, 2021
7:00 am ET
Globe Newswire
July 09, 2021
8:00 am ET
Globe Newswire
June 28, 2021
11:29 am ET
MarketWatch
June 15, 2021
8:06 am ET
Globe Newswire
June 14, 2021
7:00 am ET
Globe Newswire
June 11, 2021
3:00 am ET
Globe Newswire
June 08, 2021
8:50 am ET
BusinessWire
June 04, 2021
8:00 am ET
Globe Newswire
June 01, 2021
8:00 am ET
Globe Newswire
May 12, 2021
10:00 am ET
Globe Newswire
May 07, 2021
8:00 am ET
Globe Newswire
May 06, 2021
8:53 am ET
Globe Newswire
May 05, 2021
4:05 pm ET
Globe Newswire
2:49 pm ET
Accesswire
May 04, 2021
8:00 am ET
Globe Newswire
April 28, 2021
7:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.